Research going back to 2010 shows a protein nicknamed “Hamlet” (Alpha-lactalbumin Made Lethal to tumor cells) that is found in breast milk, could be beneficial in the fight against more than 40 different types of cancer.
The health benefits of breast milk have long been flouted, whilst Colostrum is typically contained within mother’s breast milk for the first week after birth.
As we know, when a baby is born there are many health benefits passed on from the mother to the baby. Such as cord blood stem cells in the umbilical cord and is why its important to not cut the cord as soon as possible, but to leave it attached to the newborn, so the baby can receive the vital stem cells they require to develop a strong immune system.
The accidental discovery of Hamlet adds further proof to the wonders of breast milk.
Much like Immunotherapy GcMAF which is a naturally occurring substance, breast milk is unlikely to kill the patient unlike chemotherapy, radiation and surgery.
Researchers from the University of Lunt in Sweden have revealed some positive results from studying the effects Hamlet has on bladder cancer patients.
In the early trials, those injected with the compound began to shed dead tumour cells through their urine within days.
“There’s something magical about Hamlet’s ability to target tumour cells and kill them,” Professor Catharina Svanborg told Mail on Sunday.
But the discovery came completely by accident while the team was researching antibiotics.
“We were looking for novel antimicrobial agents, and new breast milk is a very good source of these,” professor Svanborg continued. “During one experiment we needed human cells and bacteria to be present, and we chose human tumour cells for practical reasons.”
Researchers believe that a reaction takes place with breast milk when it hits the gut. It produces a protein called alpha-lactalbumin, which targets cancer cells.
The breast milk compound targets cancer cells alone, offering an alternative to chemotherapy and radiotherapy treatments, which can damage both healthy and cancerous cells in the body.
And so we see that the cure for cancer can come from the very substance that sustained us during the earliest stage of our lives. Mother nature is a wonderful provider.
The surprise discovery triggered further studies to find out if Hamlet could have similar effects on patients with cervical and bowel cancer after trials on bladder cancer patients yielded positive results.
Hamlet attacked cancer cells by side-stepping the cells’ outer defenses and going for the mitochondria, which is the cell’s power station. After that, it proceeded to the nucleus, cutting off the cell’s energy source, resulting in apoptosis, which is suicide for cells.
“To our amazement, when we added this compound of milk, the tumor cells died. It was a totally serendipitous discovery,” added Professor Svanborg, who had been studying breast milk for the past two decades. She and post-graduate student Anders Hakansson were initially experimenting with breast milk to figure out how it fights off germs when they made the discovery.
Svanborg patented the discovery and published her work, only to be met with skepticism. But years of continuous research helped her break new grounds and slowly win over critics. Her team has now gathered conclusive scientific data that show Hamlet can kill more than 40 cancers.
The tests were conducted on humans and animals. They discovered that Hamlet limited the development of brain tumor and bladder and colon cancer in mice. In a human test, nine bladder cancer patients were administered with Hamlet a week before surgery.
The result: Eight patients passed tumor cells in their urine two hours after the treatment.
Cancer is the second most common cause of death in the country. According to the American Cancer Society, approximately 600,920 Americans are expected to succumb to the disease in 2017. That’s more than 1,000 patients per day.
Fred Whitelaw, 64, was diagnosed with bowel cancer back in 2015. His daughter, Jill Turner, who had just given birth, read about breast milk’s purported effects on cancer cells. She started giving her dad excess breast milk. Although there’s still no definite scientific results, Whitelaw believed he had nothing to lose.
The game-changing discovery provides hope for all cancer patients. Svanborg’s team has already discovered how to mass produce a synthetic form of Hamlet, which means it can now be developed into a treatment.
Source: Natural News
Please see below for the latest news and research on Hamlet
Cancer and Breast milk
As good as this news is, there are of course certain “watch outs.”
For as we have seen that Pharmaceutical companies like to also add other alien and toxic ingredients to vaccines
See this section for the many health warnings of vaccines and the link to cancer, Autism
And as we have seen with the dairy industry, what we buy on the shelf can end up bearing no resemblance to the natural original. Pasteurisation and the industrial process means that there is often zero nutritional benefit to cow’s milk in a carton. Now complete with added ingredients called forever chemicals that in fact can cause cancer so this is far from simple and as we say, still at the research stage.
The breast is best
So we at Healing Oracle say, if breast milk is proven to be of a benefit to cancer patients, then perhaps the best thing to do is, as the example above, is to seek out a healthy mother with healthy breast milk that has some to spare!
And as we often have to point out; health is down to the individual. The healthier the mother, the better her milk will be. For mums that exercise regularly and have a balanced diet that is high in nutrition and low in refined sugar and processed foods, then her breast milk will be full of nutrition and far more beneficial.
But, if on the other hand, the mother’s diet is low in nutrition and high in processed foods and sugars, whilst she also gets little in terms of exercise, so the weaker her immune system will be and the less beneficial her resulting breast milk will also be.
A mother’s milk is natures best way of providing her off spring with the essential immune responses and antibodies, as their baby’s not yet developed their own immune system and so the colostrum in her milk provides the natural boost they need for these early weeks of life in the big bad world.
So if you are looking for a source of good breast milk, then make sure you find a healthy donor!
What if there were breast milk donor banks like there are blood banks?
This way healthy mothers with healthy babies can donate their milk to others? Breast milk is the best and healthiest milk of all.
Latest research on Hamlet
HAMLET Pharma Announced the Results of the First Major Clinical Trial. Published: Jul 22, 2019
LUND, Sweden, July 22, 2019 /PRNewswire/ — A research group in Lund led by Professor Catharina Svanborg discovered in 1995 that a component of human breast milk kills tumor cells without harming mature, healthy cells. Further experiments and studies have shown that the effect is due to the most common protein in human milk, alpha-lactalbumin, but in a new shape, bound to oleic acid. This new biological complex was called Human Alpha-lactalbumin Made Lethal to tumor cells, abbreviated HAMLET, and is a tumoricidal protein-lipid complex, formed by two GRAS (generally regarded as safe) molecules present in human milk. The novel therapeutic entity HAMLET is formed specifically when the human milk protein alpha-lactalbumin undergoes a conformational change and binds to oleic acid.
HAMLET Pharma is proud to announce the successful outcome of the Phase I/II trial, aimed at studying the safety and efficacy of Alpha1H in patients with bladder cancer. The first data analysis has revealed highly significant differences between the Alpha1H treated patients and the placebo group, for several crucial efficacy variables. Treatment was also shown to be safe, as no drug-related side effects were observed.
Alpha1H triggered significant shedding of cells in all tumor patients, who received the treatment (p< 0.0001).In addition, Alpha1H triggered the excretion of whole tumor fragments into the urine (p<0.0001), illustrating the potent effect compared to the placebo group.
“This is a bench-to-bedside moment and we are grateful to all, who have made this possible. The results inspire us to continue the efforts making Alpha1H available to cancer patients,” says Catharina Svanborg, founder, CMO and chairman of the board of Hamlet Pharma Ltd.
“This is a very important milestone for the company. We need more evidence but hopefully this could be the gentle chemotherapy of the future,” says Mats Persson, CEO of Hamlet Pharma Ltd.
Alpha1H triggered cell death in the tumor, as shown by cytolysis and apoptosis, a beneficial form of cell death. These findings support the key mechanisms of action of Alpha1H discovered in the laboratory and the successful translation from the laboratory to the clinic.
Carefully selected safety variables were recorded according to safety guidelines. The effects of Alpha1H occurred without drug-related side effects in the patients, consistent with the lack of toxicity observed in animal models of bladder cancer.
The clinical trial of 40 patients (20 placebo and 20 with treatment who received 6 infusions over 22 days) has been a technical success, due to the competence and commitment of the different study teams involved. A team of experts at the Motol University Hospital in Prague handled patient enrolment, clinical care, pathology assessments and treatment. The study was monitored by a highly renowned, clinical trial CRO in Prague. Scientific coordination was from Lund University, where research sample analysis was handled and molecular information obtained. Additional study variables will be communicated as soon as data is available.
HAMLET Pharma plans to conduct further studies in bladder cancer and several other cancer indications, such as colon cancer and brain tumors; all hard to cure with current therapies. HAMLET Pharma has 35 patents for the manufacturing and use of HAMLET as well as the second-generation Alpha1H derivative of the HAMLET molecule. HAMLET has been found to kill more than forty types of cancer cells to date in laboratories. The work has been published in leading international journals like The New England Journal of Medicine, GUT commented in Nature Reviews Gastroenterology and PNAS (Proceedings of the National Academy of Science, USA).
So it remains to be seen as to the true effectiveness of the resulting products and supplements of what is a synthetic substance. So we er on the side of caution before we fully celebrate its general release.
This article is for educational purposes only.
We do the research, you decide
Love and Light
The Healing Oracle Team
Please join our growing numbers on MeWe: Healing Oracle
Also join us on Twitter | YouTube
Please sign our global petition against enforced vaccinations The intention of this petition is to present 5 million signatures to each President, Prime Minister, Health Minister and heads of state worldwide.
Vaccines are a global problem and need to be tackled on a global level.
If we stand as one, we have a chance of saving the children of the future.